Failure of a conservative treatment of a placenta accreta;Échec d'un traitement conservateur d'un placenta accreta

Gynecologie Obstetrique et Fertilite

Volumn 34, Issue 11, 2006, Pages 1055-1057

  Guillot, E ^a   Raynal, P ^a   Fuchs, F ^a   Lepercq, J ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Conservative treatment; Embolization; Hysterectomy; Placenta accreta; Thrombosis

Indexed keywords

AMOXICILLIN; CEFIXIME; CEFOTAXIME; CLAVULANIC ACID; GENTAMICIN; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; OXYTOCIN;

ADULT; ANTIBIOTIC THERAPY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; CASE REPORT; CESAREAN SECTION; CLINICAL EXAMINATION; CONSERVATIVE TREATMENT; ENDOMETRITIS; ENDOMETRIUM ABLATION; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HOME CARE; HUMAN; HYPERTENSION; HYSTERECTOMY; ILIAC ARTERY; INTERMETHOD COMPARISON; PLACENTA ACCRETA; POSTOPERATIVE COMPLICATION; PUERPERAL INFECTION; RISK; SCIATIC NERVE; TACHYCARDIA; THROMBECTOMY; TREATMENT FAILURE; URINARY TRACT INFECTION; VASOSPASM; PREGNANCY; RISK FACTOR;

ADULT; CESAREAN SECTION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYSTERECTOMY; ILIAC ARTERY; PLACENTA ACCRETA; PREGNANCY; RISK FACTORS; TREATMENT FAILURE;

EID: 33751426213     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2006.06.022     Document Type: Article

References (12)

1. Miller D.A., Cholet J.A., and Goodwin T.M. Clinical risk factors for placenta previa-placenta accreta. Am. J. Obstet. Gynecol. 177 (1997) 210-214
2. O'Brien J.M., Barton J.R., and Donaldson E.S. The management of placenta percreta: conservative and operative strategies. Am. J. Obstet. Gynecol. 175 (1996) 1632-1638
3. o 266. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. 77 (2002) 77-78
4. Legro R.S., Price F.V., Hill L.M., and Caritis S.N. Nonsurgical management of placenta percreta : a case report. Obstet. Gynecol. 83 (1994) 847-849
5. Palacios Jaraquemada J.M., and Bruno C.H. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet. Gynecol. Scand. 84 8 (2005) 716
6. Papiernik E., Pons J.C., and Hessabi M. Obstetrical outcome in 454 women exposed to diethylstilbestrol during their fetal life: a case-control analysis. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34 1 Pt 1 (2005) 33-40
7. Oyelese Y., and Smulian J.C. Placenta Previa, Placenta Accreta, and Vasa Previa. Obstet. Gynecol. 107 4 (2006) 927-941
8. Kayem G., Davy C., Goffinet F., Thomas C., Clément D., and Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet. Gynecol. 104 (2004) 531-536
9. Butt K., Gagnon A., and Delisle M.F. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet. Gynecol. 99 (2002) 981-982
10. Gupta D., and Sinha R. Management of placenta accreta with oral methotrexate. Int J Gynecol Obstet 60 (1998) 171-173
11. Lepage J.P., Le Dref O., Jacob D., Soyer P., Herbreteau D., and Rymer R. Selective arterial embolisation of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet. Gynecol. Scand. 78 (1999) 698-703
12. Fiori O., Berkane N., and Uzan S. Conservative versus extirpative management in cases of placenta accreta. Obstet. Gynecol. 105 (2005) 219-220